EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, GLPGF: Galapagos N.V.

01 Dec 2025
LAST:

31.29

CHANGE:
 2.16		OPEN:
31.29		HIGH:
31.29		ASK:
0.00		VOLUME:
1.0K
CHG(%):
6.46		PREV:
33.45		LOW:
31.29		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Galapagos N.V.
About:Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Sector:Healthcare
Industry:Biotechnology
Address:Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Website:https://www.glpg.com
CIK:0001421876
ISIN:BE0003818359
FIGI:BBG000FVZZN3
LEI:549300QKJ78IY0IOV655

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:28.659.2%
MA10:26.6517.4%
Week High:31.290.0%
Week Low:31.290.0%